BLINKBIO
BlinkBio is a biotechnology company formed to exploit Bioorthogonal Linker (“BLink”) chemistries through their Tunable Drug Conjugates (TDCs) platform for the treatment of oncology and other diseases. It has assembled a modular toolbox of components allowing the design of Tunable Drug Conjugates a new class of Drug Conjugate therapies for the treatment of cancer. The company's TDC platform comprises a modular set of ligands, linkers, and payloads with aligned characteristics to enable both rapid payload release in the tumor and rapid systemic clearance of the parent drug conjugate. It was founded in 2009 and is headquartered in Jupiter, Florida.
BLINKBIO
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2009-01-01
Address:
Jupiter, Florida, United States
Country:
United States
Website Url:
http://www.blinkbioinc.com
Total Employee:
1+
Status:
Active
Contact:
(800)983-8098
Email Addresses:
[email protected]
Total Funding:
20.67 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins GoDaddy DNS OpenResty GoDaddy SSL
Similar Organizations
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Florida Institute for the Commercialization of Florida Technology
Florida Institute for the Commercialization of Florida Technology investment in Venture Round - BlinkBio
Official Site Inspections
http://www.blinkbioinc.com
- Host name: 172.67.209.222
- IP address: 172.67.209.222
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
